In breast cancers, SQLE overexpression often indicates a more aggressive tumor (17) and is associated with tumor recurrence and short overall survival time, including estrogen receptor-positive (ER(+)) breast cancer and estrogen receptor-negative breast cancer or luminal A subtype and luminal B subtype (14, 16, 79, 80). Here, ESR1 is linked to breast cancer.